Astrana Health (NASDAQ:ASTH) Sees Large Volume Increase – Here’s Why

Astrana Health, Inc. (NASDAQ:ASTH) shares saw strong trading volume on Friday . 288,697 shares traded hands during trading, a decline of 16% from the previous session’s volume of 341,991 shares.The stock last traded at $28.21 and had previously closed at $33.36.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ASTH shares. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astrana Health in a report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, Astrana Health presently has an average rating of “Moderate Buy” and an average target price of $47.40.

Astrana Health Trading Down 17.0%

The firm has a 50-day moving average price of $30.57 and a 200 day moving average price of $27.96. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 54.32, a price-to-earnings-growth ratio of 0.90 and a beta of 0.80. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The firm had revenue of $317.00 million during the quarter. As a group, sell-side analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current year.

Hedge Funds Weigh In On Astrana Health

Institutional investors have recently made changes to their positions in the stock. Covestor Ltd boosted its holdings in shares of Astrana Health by 777.6% during the first quarter. Covestor Ltd now owns 2,001 shares of the company’s stock valued at $62,000 after acquiring an additional 1,773 shares during the period. Tower Research Capital LLC TRC grew its stake in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares in the last quarter. State of Wyoming bought a new stake in shares of Astrana Health during the second quarter valued at about $132,000. AlphaQuest LLC lifted its holdings in Astrana Health by 144.2% in the first quarter. AlphaQuest LLC now owns 4,883 shares of the company’s stock worth $151,000 after purchasing an additional 2,883 shares during the period. Finally, US Bancorp DE increased its stake in Astrana Health by 21.3% during the 1st quarter. US Bancorp DE now owns 5,791 shares of the company’s stock valued at $180,000 after buying an additional 1,015 shares during the period. 52.77% of the stock is owned by institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.